Kresnier Perez

The preclinical phase of medical research serves as a critical foundation for the development of new therapies and interventions. This stage typically involves laboratory and animal studies designed to assess the safety, efficacy, and biological activity of a potential drug or treatment before it is tested in humans. Researchers utilize various models, including cell cultures […]

Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer that accounts for approximately 10-15% of all lung cancer cases. Characterized by its rapid growth and early metastasis, SCLC is often diagnosed at an advanced stage, which significantly complicates treatment options and prognosis. The cancer originates in the neuroendocrine cells of the

Lung cancer remains one of the most prevalent and deadly forms of cancer worldwide, accounting for a significant number of cancer-related deaths each year. According to the World Health Organization, lung cancer is responsible for approximately 1.8 million deaths annually, making it the leading cause of cancer mortality globally. The disease primarily arises from the

The role of a Certified Clinical Research Coordinator (CCRC) is pivotal in the landscape of clinical trials and medical research. These professionals serve as the linchpin between various stakeholders, including sponsors, investigators, and regulatory bodies. Their primary responsibility is to oversee the day-to-day operations of clinical trials, ensuring that they are conducted in accordance with

Icon Clinical Studies, a prominent global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries, has established itself as a leader in the realm of clinical research. Founded in 1990, Icon has grown exponentially, driven by a commitment to advancing medical science through rigorous clinical trials. The organization operates

Icon Clinical Trials is a prominent global provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. Established with the mission to accelerate the development of new therapies, Icon has become synonymous with high-quality clinical research. The organization operates in over 40 countries, leveraging a vast network of clinical sites

Clinical research is a systematic investigation designed to develop or contribute to generalizable knowledge regarding human health and disease. It encompasses a wide range of studies, from early-phase trials that test new drugs or therapies to observational studies that gather data on health outcomes in specific populations. The primary goal of clinical research is to

Clinical research studies are systematic investigations designed to evaluate the safety and efficacy of new medical interventions, including drugs, devices, and treatment protocols. These studies are essential for advancing medical knowledge and improving patient care. They typically involve human participants and can be categorized into several phases, each with distinct objectives. Phase I trials primarily

AbbVie, a global biopharmaceutical company, is at the forefront of developing innovative therapies that address some of the most challenging health issues today. Clinical trials are a critical component of AbbVie’s research and development process, serving as the bridge between laboratory discoveries and real-world applications. These trials are meticulously designed to evaluate the safety and

Fenbendazole is a broad-spectrum anthelmintic agent primarily used in veterinary medicine to treat parasitic infections in animals, particularly in livestock and pets. Its efficacy against a variety of helminths has made it a staple in veterinary pharmacology. However, recent interest has emerged regarding its potential application in oncology, particularly as a complementary treatment for cancer.